Torrent Pharmaceuticals Limited

TORNTPHARM.NS

TORNTPHARM.NSTorrent Pharmaceuticals Limited IN flag

National Stock Exchange of India

3,164.00

INR

-63.00

(-1.95%)

56.34EPS

56.16P/E

1.07TMarket Cap

Jul 21Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

ISIN

INE685A01028

CUSIP

Y8896L148

Return %

Stock

S&P500

9.65

9.22

128.75

59.29

148.80

93.57

Use logarithmic scale

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	TTM
Revenue per Share	90.07	119.14	135.29	192.63	167.59	172.11	220.47	229.87	233.01	248.75	279.62	312.14	334.42	334.45
Basic EPS, GAAP	12.79	19.62	22.19	51.21	27.58	20.04	12.89	30.28	36.99	22.96	36.79	48.94	56.47	56.48
Free Cash Flow per Basic Share	-4.12	5.89	16.77	63.32	15.42	3.04	33.54	29.14	49.35	47.29	53.01	83.72	58.33	- -
Dividend per Share	2.47	7.9	5.9	24.81	6.02	7.82	9.15	21.23	10	20	25.5	30	32	- -
Book Value per Share	10.63	23.39	41.71	45.11	47.24	48.41	50.26	58.43	85.42	88.68	102.6	121.51	4.99	4.99
Tangible Book Value per Share	41.36	55.38	21.64	47.59	73.19	-30.7	-10.65	3.19	44.63	63.45	22.78	57.19	88.32	88.33
Basic Weighted Avg Shares	338	338	338	338	338	338	338	338	338	338	338	338	338	338
Sales/Revenue/Turnover	30,485	40,323	45,788	65,194	56,722	58,248	74,618	77,800	78,862	84,188	94,637	105,620	113,170	113,170
Operating Margin (%)	20.55	23.62	18.11	38.82	19.11	16.15	18.34	19.52	23.11	21.02	22.61	24.24	25.85	25.85
Depreciation Expense	827	870	1,907	2,376	3,069	4,086	6,177	6,544	6,573	6,619	7,020	8,080	7,950	7,950
Net Income, GAAP	4,328	6,639	7,509	17,332	9,336	6,781	4,363	10,247	12,519	7,772	12,452	16,560	19,110	19,110
Effective Tax Rate (%)	25.22	21.34	20.09	26.04	14.2	27.16	22.32	13.64	17.98	36.6	32.59	29.59	28.51	28.51
Profit Margin (%)	14.2	16.46	16.4	26.59	16.46	11.64	5.85	13.17	15.87	9.23	13.16	15.68	16.89	16.89
Working Capital	8,502	12,299	13,938	14,027	21,411	602	-1,278	-4,751	6,299	7,499	-1,336	1,862	9,060	9,060
LT Debt	4,545	7,445	21,729	18,501	22,408	41,115	39,129	33,038	29,633	21,600	25,492	16,682	13,380	13,380
Total Equity	14,223	19,028	26,434	34,946	43,506	46,227	47,244	48,232	58,372	59,530	61,981	68,562	75,910	75,910
Return on Invested Capital (%)	24.26	29.38	15.86	33.28	14.57	7.62	9.71	12.21	13.96	10.78	13.33	15.94	19.08	19.08
Return on Capital (%)	48.78	46.41	28.88	46.61	27.73	14.74	10.42	18.15	19.76	12.64	18.47	22.45	36.35	36.35
Return on Common Equity (%)	152.09	115.31	68.17	117.98	59.74	41.9	26.13	55.71	51.43	26.38	38.47	43.67	89.29	89.29

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	10.37%	7.86%	7.15%
Net Income, GAAP	24.94%	18.57%	15.4%
Free Cash Flow	121.66%	20.98%	-30.32%
Total Cash Common Dividend	52.27%	19.78%	6.7%
Total Equity	11.57%	9.69%	10.72%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Company Description

CEO: Mr. Sanjay Gupta
Full Time Employees: 15,718
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Address: Torrent House Ahmedabad India 380009
IPO Date: Jul 1, 2002
Website: torrentpharma.com
Similar Companies: Suven Life Sciences Limited (SUVEN.NS)
Anbc, Inc. (SYUP)
Steep Hill Inc. (STPH.CN)
LiveWire Ergogenics, Inc. (LVVV)
Dr. Reddy's Laboratories Limited (DRREDDY.BO)
Brooks Laboratories Limited (BROOKS.BO)
Business: Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally. It offers products in various therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, women healthcare, diabetology, pain management, gynecology, oncology, and anti-infective, as well as provides vitamins, minerals, and nutrients. The company also provides contract manufacturing services. It has licensing collaborations of Baricitinib, Molnupiravir, and Paxlovid for its Covid portfolio. Torrent Pharmaceuticals Limited was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.

	Sep'25	Dec'25	Mar'25
ST Debt	16,520	- -	18,640
LT Borrowings	14,140	- -	11,920
LT Finance Leases	600	- -	1,460
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	338	- -	338
Market Capitalization	1,140,553	1,128,154	1,092,256

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	TTM
Revenue per Share	90.07	119.14	135.29	192.63	167.59	172.11	220.47	229.87	233.01	248.75	279.62	312.14	334.42	334.45
Basic EPS, GAAP	12.79	19.62	22.19	51.21	27.58	20.04	12.89	30.28	36.99	22.96	36.79	48.94	56.47	56.48
Free Cash Flow per Basic Share	-4.12	5.89	16.77	63.32	15.42	3.04	33.54	29.14	49.35	47.29	53.01	83.72	58.33	- -
Dividend per Share	2.47	7.9	5.9	24.81	6.02	7.82	9.15	21.23	10	20	25.5	30	32	- -
Book Value per Share	10.63	23.39	41.71	45.11	47.24	48.41	50.26	58.43	85.42	88.68	102.6	121.51	4.99	4.99
Tangible Book Value per Share	41.36	55.38	21.64	47.59	73.19	-30.7	-10.65	3.19	44.63	63.45	22.78	57.19	88.32	88.33
Basic Weighted Avg Shares	338	338	338	338	338	338	338	338	338	338	338	338	338	338
Sales/Revenue/Turnover	30,485	40,323	45,788	65,194	56,722	58,248	74,618	77,800	78,862	84,188	94,637	105,620	113,170	113,170
Operating Margin (%)	20.55	23.62	18.11	38.82	19.11	16.15	18.34	19.52	23.11	21.02	22.61	24.24	25.85	25.85
Depreciation Expense	827	870	1,907	2,376	3,069	4,086	6,177	6,544	6,573	6,619	7,020	8,080	7,950	7,950
Net Income, GAAP	4,328	6,639	7,509	17,332	9,336	6,781	4,363	10,247	12,519	7,772	12,452	16,560	19,110	19,110
Effective Tax Rate (%)	25.22	21.34	20.09	26.04	14.2	27.16	22.32	13.64	17.98	36.6	32.59	29.59	28.51	28.51
Profit Margin (%)	14.2	16.46	16.4	26.59	16.46	11.64	5.85	13.17	15.87	9.23	13.16	15.68	16.89	16.89
Working Capital	8,502	12,299	13,938	14,027	21,411	602	-1,278	-4,751	6,299	7,499	-1,336	1,862	9,060	9,060
LT Debt	4,545	7,445	21,729	18,501	22,408	41,115	39,129	33,038	29,633	21,600	25,492	16,682	13,380	13,380
Total Equity	14,223	19,028	26,434	34,946	43,506	46,227	47,244	48,232	58,372	59,530	61,981	68,562	75,910	75,910
Return on Invested Capital (%)	24.26	29.38	15.86	33.28	14.57	7.62	9.71	12.21	13.96	10.78	13.33	15.94	19.08	19.08
Return on Capital (%)	48.78	46.41	28.88	46.61	27.73	14.74	10.42	18.15	19.76	12.64	18.47	22.45	36.35	36.35
Return on Common Equity (%)	152.09	115.31	68.17	117.98	59.74	41.9	26.13	55.71	51.43	26.38	38.47	43.67	89.29	89.29

Year	Q1	Q2	Q3	Q4	FY
2023	10.45	9.02	8.63	- -	36.79
2024	11.18	11.39	13.1	- -	48.94
2025	13.51	13.37	14.88	- -	56.47

Year	Q1	Q2	Q3	Q4	FY
2023	22,920	22,610	24,590	24,517	94,637
2024	25,480	26,280	26,910	26,953	105,620
2025	28,150	28,310	27,620	29,090	113,170

	Sep'25	Dec'25	Mar'25
Total Current Assets	58,790	- -	56,230
Accounts Receivable, Net	17,830	- -	18,670
Cash, Cash Equivalents & STI	14,830	- -	8,740
Inventories	22,710	- -	25,410
Total Current Liabilities	48,470	- -	47,170
Payables & Accruals	- -	- -	- -
ST Debt	16,520	- -	18,640
Deferred Revenue	- -	- -	- -

Torrent Pharmaceuticals Limited

Growth Rates

(avg. rate of change)

Company Description

Growth Rates

(avg. rate of change)

Capital Structure

Working Capital

Quarterly Dividends Per Share

Year

Quarterly Earnings Per Share

Year

Quarterly Revenue

Year